Icra sees pharma industry growth tapering to 7-10% over FY18-FY20Post published:July 4, 2017Post category:Industry NewsThe Indian pharma industry is likely to witness a slowdown in growth because of pricing pressure and regulatory interventions in the US, according to an Icra report Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndoStar Capital close to acquiring ICICI Home Finance Next PostGST rates: Footwear to cost more as firms look to increase prices by 5-7% You Might Also Like The FedEx Competition is coming to India to help Small E-commerce Businesses Go Global May 4, 2017 Festo introduces linear axes ELGC and mini slide EGSC electric actuators September 10, 2018 Flipkart may relaunch loyalty programme to take on Amazon Prime October 18, 2017